325 related articles for article (PubMed ID: 32330332)
1. SARS-CoV-2 infection in children - Understanding the immune responses and controlling the pandemic.
Lu X; Xiang Y; Du H; Wing-Kin Wong G
Pediatr Allergy Immunol; 2020 Jul; 31(5):449-453. PubMed ID: 32330332
[TBL] [Abstract][Full Text] [Related]
2. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
[TBL] [Abstract][Full Text] [Related]
3. Establishment of a pediatric COVID-19 biorepository: unique considerations and opportunities for studying the impact of the COVID-19 pandemic on children.
Lima R; Gootkind EF; De la Flor D; Yockey LJ; Bordt EA; D'Avino P; Ning S; Heath K; Harding K; Zois J; Park G; Hardcastle M; Grinke KA; Grimmel S; Davidson SP; Forde PJ; Hall KE; Neilan AM; Matute JD; Lerou PH; Fasano A; Shui JE; Edlow AG; Yonker LM
BMC Med Res Methodol; 2020 Sep; 20(1):228. PubMed ID: 32917141
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 Infection in Children: Special Considerations.
Khan L
Pediatr Ann; 2020 Oct; 49(10):e407-e412. PubMed ID: 33034653
[TBL] [Abstract][Full Text] [Related]
5. Immunopathogenesis of COVID-19: Summary and Possible Interventions.
Jacques FH; Apedaile E
Front Immunol; 2020; 11():564925. PubMed ID: 33072103
[TBL] [Abstract][Full Text] [Related]
6. SARS - CoV-2: Reasons of epidemiology of severe ill disease cases and therapeutic approach using trivalent vaccine (tetanus, diphtheria and Bordetella pertussis).
Ietto G
Med Hypotheses; 2020 Aug; 141():109779. PubMed ID: 32387756
[TBL] [Abstract][Full Text] [Related]
7. Early Insights into Immune Responses during COVID-19.
St John AL; Rathore APS
J Immunol; 2020 Aug; 205(3):555-564. PubMed ID: 32513850
[TBL] [Abstract][Full Text] [Related]
8. Severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) infection during late pregnancy: a report of 18 patients from Wuhan, China.
Zhang L; Dong L; Ming L; Wei M; Li J; Hu R; Yang J
BMC Pregnancy Childbirth; 2020 Jul; 20(1):394. PubMed ID: 32641013
[TBL] [Abstract][Full Text] [Related]
9. The role of passive immunization in the age of SARS-CoV-2: an update.
Fischer JC; Zänker K; van Griensven M; Schneider M; Kindgen-Milles D; Knoefel WT; Lichtenberg A; Tamaskovics B; Djiepmo-Njanang FJ; Budach W; Corradini S; Ganswindt U; Häussinger D; Feldt T; Schelzig H; Bojar H; Peiper M; Bölke E; Haussmann J; Matuschek C
Eur J Med Res; 2020 May; 25(1):16. PubMed ID: 32404189
[TBL] [Abstract][Full Text] [Related]
10. [Coronavirus and COVID-19 : focus on a galopping pandemic].
Davenne E; Giot JB; Huynen P
Rev Med Liege; 2020 Apr; 75(4):218-225. PubMed ID: 32267109
[TBL] [Abstract][Full Text] [Related]
11. Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19).
Chang FY; Chen HC; Chen PJ; Ho MS; Hsieh SL; Lin JC; Liu FT; Sytwu HK
J Biomed Sci; 2020 Jun; 27(1):72. PubMed ID: 32498686
[TBL] [Abstract][Full Text] [Related]
12. Coronavirus diseases and pregnancy: COVID-19,SARS, and MERS.
Fathi M; Vakili K; Deravi N; Yaghoobpoor S; Ahsan E; Mokhtari M; Moshfeghi M; Vaezjalali M
Przegl Epidemiol; 2020; 74(2):276-289. PubMed ID: 33112124
[TBL] [Abstract][Full Text] [Related]
13. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
Frederiksen LSF; Zhang Y; Foged C; Thakur A
Front Immunol; 2020; 11():1817. PubMed ID: 32793245
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
Wei J; Zhao J; Han M; Meng F; Zhou J
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32727811
[TBL] [Abstract][Full Text] [Related]
15. Host Immune Response Driving SARS-CoV-2 Evolution.
Wang R; Hozumi Y; Zheng YH; Yin C; Wei GW
Viruses; 2020 Sep; 12(10):. PubMed ID: 32992592
[TBL] [Abstract][Full Text] [Related]
16. Potential Maternal and Infant Outcomes from (Wuhan) Coronavirus 2019-nCoV Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections.
Schwartz DA; Graham AL
Viruses; 2020 Feb; 12(2):. PubMed ID: 32050635
[TBL] [Abstract][Full Text] [Related]
17. Disappearance of SARS-CoV-2 Antibodies in Infants Born to Women with COVID-19, Wuhan, China.
Gao J; Li W; Hu X; Wei Y; Wu J; Luo X; Chen S; Chen L
Emerg Infect Dis; 2020 Oct; 26(10):2491-2494. PubMed ID: 32620180
[TBL] [Abstract][Full Text] [Related]
18. How to reduce the likelihood of coronavirus-19 (CoV-19 or SARS-CoV-2) infection and lung inflammation mediated by IL-1.
Conti P; Gallenga CE; Tetè G; Caraffa A; Ronconi G; Younes A; Toniato E; Ross R; Kritas SK
J Biol Regul Homeost Agents; 2020 March-April,; 34(2):333-338. PubMed ID: 32228825
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular Disease and SARS-CoV-2: the Role of Host Immune Response Versus Direct Viral Injury.
Biscetti F; Rando MM; Nardella E; Cecchini AL; Bruno P; Landolfi R; Flex A
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33143371
[TBL] [Abstract][Full Text] [Related]
20. The Potential Effect of Novel Coronavirus SARS-CoV-2 on NK Cells; A Perspective on Potential Therapeutic Interventions.
Jewett A
Front Immunol; 2020; 11():1692. PubMed ID: 32754162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
